• 2025.10.22 (Wed)
  • All articles
  • LOGIN
  • JOIN
Global Economic Times
APEC2025KOREA가이드북
  • Synthesis
  • World
  • Business
  • Industry
  • ICT
  • Distribution Economy
  • Korean Wave News
  • Opinion
  • Arts&Culture
  • Sports
  • People & Life
  • Lee Yeon-sil Column
  • Ko Yong-chul Column
  • Photo News
  • New Book Guide
  • Cherry Garden Story
MENU
 
Home > Synthesis

"Miracle Obesity Drug" Wegovy Sees Surging Pancreatitis Side Effects, Including Reported Deaths

Hwang Sujin Reporter / Updated : 2025-06-28 09:50:53
  • -
  • +
  • Print
Safety concerns grow over GLP-1 class obesity treatments; UK health authorities launch genetic analysis.

Concerns about the safety of GLP-1 class obesity treatments, including Wegovy (semaglutide), often dubbed "miracle obesity drugs" and garnering global attention, are escalating due to a series of acute pancreatitis cases. In the UK, in particular, over 400 adverse event reports, including more than 10 deaths, have prompted health authorities to investigate the situation.

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England recently requested official reports of acute pancreatitis symptoms experienced by patients after taking GLP-1 class treatments such as Wegovy, Ozempic (semaglutide), Zepbound/Mounjaro (tirzepatide), and Saxenda (liraglutide). Notably, over a quarter of all reported cases this year have occurred recently, with tirzepatide-related cases accounting for nearly half.

Acute pancreatitis is a severe inflammation of the pancreas accompanied by abdominal pain, vomiting, and fever, and can be life-threatening in severe cases. The pancreas is a vital organ that secretes blood sugar-regulating hormones like insulin and glucagon, as well as digestive enzymes. When pancreatitis occurs, these functions can be severely compromised.

Currently, some studies suggest that GLP-1 compounds may increase the risk of pancreatitis. GLP-1 analogues are associated with the proliferation of pancreatic beta cells and the promotion of insulin secretion, and some opinions suggest this process could put a strain on the pancreas. However, pharmaceutical companies only list pancreatitis as an "uncommon reaction" in product information and state that these symptoms have not been directly confirmed as being caused by the treatments.

In response, experts point out that rapid weight loss can lead to gallstone formation, which may induce pancreatitis. When weight is lost rapidly, the composition of bile can change, or bile excretion may not be smooth, increasing the risk of gallstone formation. If these gallstones block the pancreatic duct, pancreatic fluid can reflux, leading to pancreatitis. Since obesity itself is a risk factor for pancreatitis, the possibility that these are phenomena occurring during obesity treatment cannot be ruled out.

Amidst this controversy, UK health authorities plan to initiate genetic analysis of patients who experienced pancreatitis symptoms after receiving GLP-1 class treatments. This aims to investigate whether specific ethnicities or genetic factors make individuals more susceptible to adverse reactions and to clarify the causal relationship between the treatments and the occurrence of pancreatitis.

As of May 13th, at least 10 reported cases to UK authorities included deaths due to pancreatitis. However, it has not yet been definitively confirmed whether the obesity drugs were the direct cause of death in all these cases.

The results of the UK health authorities' investigation are expected to further intensify the safety debate surrounding GLP-1 class treatments, once hailed as "miracle obesity drugs." For patients choosing medication for obesity treatment, a thorough understanding of their individual health status, potential side effects, and consultation with a healthcare professional are becoming even more crucial.

[Copyright (c) Global Economic Times. All Rights Reserved.]

  • #NATO
  • #OTAN
  • #OECD
  • #G20
  • #globaleconomictimes
  • #Korea
  • #UNPEACEKOR
  • #micorea
  • #mykorea
  • #UN
  • #UNESCO
  • #nammidonganews
  • #sin
Hwang Sujin Reporter
Hwang Sujin Reporter

Popular articles

  • A Chemical Revolution, the Era of Metal-Organic Frameworks (MOFs) Begins: 2025 Nobel Prize in Chemistry

  • Teenagers' Silent Cries for Help: A Self-Harm and Suicide Attempt Every 10 Minutes

  • The Gate to the Macroscopic World Opened by Quantum Physics: John Clarke, Michel Devoret, and John Martinis Awarded the 2025 Nobel Prize in Physics

I like it
Share
  • Facebook
  • X
  • Kakaotalk
  • LINE
  • BAND
  • NAVER
  • https://globaleconomictimes.kr/article/1065574215652529 Copy URL copied.
Comments >

Comments 0

Weekly Hot Issue

  • South Korea to Drastically Increase Domestic LNG Shipping Rate to 70%
  • 'Export Boom-Up Korea Week' Kicks Off as Nation Prepares to Host APEC
  • Japan Elects Ultraconservative Sanae Takaichi as First Female Prime Minister: The 'Female Abe' Ascends
  • Trump Pressured Zelensky to 'Accept Russia's Demands or Be Destroyed,' Report from FT Reveals
  • Kering Sells Beauty Division to L'Oréal for €4 Billion Amid Gucci Slump 
  • NATO Deputy Secretary General Pledges to Strengthen Substantive Cooperation with South Korea, Including Defense Industry

Most Viewed

1
The Imminent Reality: Donald Trump's Unlikelihood for the Nobel Peace Prize as a Destroyer of International Order
2
Renewable Energy Covers 100% of Global Electricity Demand Growth in H1 2025, Marking a Turning Point in the Fossil Fuel Era
3
McDonald's 'Subtle Racism' Controversy: Korean American Denied Order After 70-Minute Wait
4
Early Winter Chill Grips South Korea as Seoraksan Sees First Snow
5
A Chemical Revolution, the Era of Metal-Organic Frameworks (MOFs) Begins: 2025 Nobel Prize in Chemistry
광고문의
임시1
임시3
임시2

Hot Issue

EU States Agree to Complete Phase-Out of Russian Gas by End of 2027

US Ships to be Built in South Korea: Washington Considers Easing Protective Maritime Laws for Alliance Shipbuilding Cooperation

South Korea to Drastically Increase Domestic LNG Shipping Rate to 70%

Japan Elects Ultraconservative Sanae Takaichi as First Female Prime Minister: The 'Female Abe' Ascends

Let’s recycle the old blankets in Jeju Island’s closet instead of incinerating them.

Global Economic Times
korocamia@naver.com
CEO : LEE YEON-SIL
Publisher : KO YONG-CHUL
Registration number : Seoul, A55681
Registration Date : 2024-10-24
Youth Protection Manager: KO YONG-CHUL
Singapore Headquarters
5A Woodlands Road #11-34 The Tennery. S'677728
Korean Branch
Phone : +82(0)10 4724 5264
#304, 6 Nonhyeon-ro 111-gil, Gangnam-gu, Seoul
Copyright © Global Economic Times All Rights Reserved
  • 에이펙2025
  • APEC2025가이드북TV
  • 세종시
Search
Category
  • All articles
  • Synthesis
  • World
  • Business
  • Industry
  • ICT
  • Distribution Economy
  • Korean Wave News
  • Opinion
  • Arts&Culture
  • Sports
  • People & Life
  • Lee Yeon-sil Column
  • Ko Yong-chul Column
  • Photo News
  • New Book Guide
  • Cherry Garden Story
  • Multicultural News
  • Jobs & Workers
  • APEC 2025 KOREA GUIDE